Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumors × TAS-119 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 1 Epilepsy 1 Advanced Solid Tumors 1

Interventions

Injections 26 Carboplatin 17 Docetaxel 14 pembrolizumab 12 Paclitaxel 11 Bevacizumab 10 durvalumab 8 Nivolumab 8 Cisplatin 8 Fluorouracil 7 Oxaliplatin 6 Leucovorin 6 trifluridine tipiracil drug combination 5 toripalimab 5 tislelizumab 5 linifanib 5 Pemetrexed 5 Capecitabine 5 zimberelimab 4 talazoparib 4 olaparib 4 Panobinostat 4 Itraconazole 4 Irinotecan 4 Gemcitabine 4 Everolimus 4 tremelimumab 3 sotorasib 3 sintilimab 3 fludarabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02448589 2024-09-04

An Investigation of TAS-119 Monotherapy

Taiho Oncology, Inc.

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡